Effects of Bladder Function by Early Tamsulosin Treatment in a Spinal Cord Injury Rat Model.
10.5535/arm.2014.38.4.433
- Author:
Kang Keun LEE
1
;
Moon Young LEE
;
Dong Yeop HAN
;
Hee Jong JUNG
;
Min Cheol JOO
Author Information
1. Department of Rehabilitation Medicine and Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea. mcjoo68@wku.ac.kr
- Publication Type:In Vitro ; Original Article
- Keywords:
Spinal cord injuries;
Tamsulosin;
Neurogenic urinary bladder
- MeSH:
Acetylcholine;
Animals;
Baths;
Blotting, Western;
Catheters;
Models, Animal*;
Rats;
rho-Associated Kinases;
Spinal Cord Injuries*;
Urinary Bladder*;
Urinary Bladder, Neurogenic;
Urination
- From:Annals of Rehabilitation Medicine
2014;38(4):433-442
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: To investigate the effects of early tamsulosin treatment on changes in bladder characteristics after a spinal cord injury. METHODS: We divided 45 rats into three groups: the control (CON) group, the spinal cord injury (SCI) group, and the SCI+tamsulosin treatment (SCI+TAM) group. Spinal cord transection was performed in the SCI and SCI+TAM groups. Tamsulosin was injected for 7 days in the SCI+TAM group. Intravesical and intra-abdominal catheters were implanted before cord injury. Basal pressure (BP), maximal vesical pressure (MVP), micturition volume (MV), and voiding interval time (VIT) were measured at 7 days after SCI. The bladder was then removed and used for an in vitro organ bath study and Western blot analysis. The percentage changes in contractility from baseline after acetylcholine alone, pretreatment with a muscarinic 2 (M2) receptor blocker (AQ-RA741), and pretreatment with a M3 receptor blocker (4-DAMP) were compared among the groups. Western blot analyses were performed to determine expression levels of pERK1/2 and rho-kinase. RESULTS: In cystometry, MVP, BP, MV, and VIT showed changes in the SCI and SCI+TAM groups versus the CON group (p<0.05). In the organ bath study, acetylcholine-induced contractility in the three groups differed significantly (p<0.05). Additionally, acetylcholine-induced contractility with 4-DAMP pretreatment was reduced significantly in the SCI+TAM group versus the SCI group. In Western blotting, pERK1/2 expression was stronger (p<0.05) and rho-kinase expression was weaker in the SCI+TAM group than the SCI group (p<0.05). CONCLUSION: These results suggest that the bladder contraction due to acetylcholine after SCI can be decreased by tamsulosin in the acute stage and this involves changes in pERK1/2 and rho-kinase.
